Maria Cecilia Hospital
| Italia | Turchia | Austria | |
| Radioterapia per il cancro colorettale | da $7,000 | da $7,000 | da $12,000 |
| Radiochirurgia stereotassica | da $25,000 | da $4,500 | da $17,000 |
| Craniotomia | da $25,000 | da $5,650 | da $20,000 |
| Chemioterapia per carcinoma mammario | da $4,500 | da $1,200 | da $15,000 |
| Halcyon | da $11,500 | da $5,400 | - |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Astrocitoma. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Astrocitoma e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Astrocitoma.
Dr. Ignazio Borghesi heads the Neurosurgery Unit at Maria Cecilia Hospital. He has performed over 4,500 complex cranial and spinal procedures. His team completes approximately 1,000 surgeries every year. Dr. Borghesi uses 4K 3D digital imaging for enhanced surgical precision. He focuses on minimally invasive techniques for brain and spinal conditions.
Italy offers specialized neuro-oncology care at JCI-accredited facilities like Maria Cecilia Hospital. Leading centers in Milan and Bologna utilize advanced 4K 3D digital microscopes. These tools allow for precise tumor removal. Multi-disciplinary teams provide comprehensive surgical and radiation therapies for glial tumors.
Bookimed Expert Insight: Italian neuro-oncology centers like Maria Cecilia Hospital often specialize in heart-brain multidisciplinary cases. This expertise is vital for patients with secondary health risks. Our data shows that top centers prioritize 200+ specialist doctors on-site. This ensures immediate access to neuro-oncologists, neurologists, and surgeons for complex glioma management.
Patient Consensus: Patients emphasize choosing centers that offer both rapid imaging and molecular tumor testing. They note that the speed of pathology results is critical for starting adjuvant treatment.
Italian neuro-oncology centers use real-time intraoperative MRI and fluorescence-guided surgery to remove brain tumors safely. These technologies help surgeons distinguish tumor margins from healthy tissue. Advanced facilities like Maria Cecilia Hospital utilize 4K 3D digital microsurgery to maintain precision through smaller incisions.
Bookimed Expert Insight: Italian centers like Maria Cecilia Hospital specialize in neurosurgery and maintain JCI accreditation for safety. Data shows these high-volume facilities often utilize a multimodal setup combining 3D digital endoscopes with real-time neurophysiological monitoring. This integrated approach is more effective than any single device for complex astrocytoma cases.
Patient Consensus: Patients value the multidisciplinary team approach and often feel reassured when awake mapping is used. They frequently highlight the importance of intraoperative imaging to ensure as much tumor as possible is removed safely.
Non-surgical options for astrocytomas are widely available in Italy. Leading oncology centers utilize stereotactic radiosurgery (SRS) and advanced radiotherapy. Systems like Gamma Knife and CyberKnife provide sub-millimeter precision. Italian facilities are highly integrated with European clinical safety networks for brain tumor care.
Bookimed Expert Insight: Italian neuro-oncology is highly centralized. Major research hospitals like Maria Cecilia Hospital often hold specialized rankings. This clinic was ranked best for neurosurgery by Bookimed patients. Facilities with over 200 doctors typically offer broader multidisciplinary teams. These teams are essential for matching treatment to a tumor's genetic profile. Focus on centers with over 14 departments to ensure comprehensive care.
Patient Consensus: Patients note that advanced treatment access depends heavily on the specific hospital. Large university centers are often better equipped for complex precision radiotherapy than local facilities.
Patients in Italy can access targeted therapies like Vorasidenib and enroll in clinical trials for IDH-mutant astrocytomas. Access is managed through the Italian Medicines Agency (AIFA). Major JCI-accredited research hospitals in Milan, Rome, and Bologna offer dual IDH1/IDH2 inhibitors and international research protocols.
Bookimed Expert Insight: Clinical trial availability in Italy changes monthly across different regions. Large JCI-accredited facilities like Maria Cecilia Hospital in Bologna specialize in complex neurosurgery and research. Patients should prioritize centers with multidisciplinary tumor boards. These boards can approve off-label inhibitors like Ivosidenib when genomic profiling justifies the usage.
Patient Consensus: Patients emphasize obtaining a full molecular diagnosis early to qualify for trials. Many recommend seeking a second opinion at major university hospitals if local clinics lack experimental protocols.
Leading Italian hospitals actively accept international patients for astrocytoma treatment through dedicated international departments. Specialized centers provide advanced neuro-oncology care. They offer microsurgery, brain mapping, and radiosurgery. Facilities often hold JCI accreditation. They coordinate medical visas and language translation for foreign nationals.
Bookimed Expert Insight: Italian centers specializing in neurosurgery are highly concentrated in the north. Maria Cecilia Hospital performs over 1,000 complex procedures annually. It is situated just 40 minutes from Bologna International Airport. This proximity is vital for recovery. Patients should look for hospitals with JCI accreditation. These facilities often maintain higher volume ratings for complex neurosurgery.
Patient Consensus: Patients note that admission is not automatic and requires a thorough record review. It is essential to provide complete MRI scans and pathology reports before traveling.
Coverage for astrocytoma in Italy depends on residency and home country. Legal residents access the state system for a fixed title. European Union citizens use health cards for emergencies. Non-residents usually pay out of pocket or use private insurance for planned neurosurgery.
Bookimed Expert Insight: While Italy offers public coverage, the 9,000 annual patients at centers like Maria Cecilia Hospital often choose private care to bypass wait times. This is vital for astrocytoma where surgical timing affects outcomes. Specialized facilities frequently hold Joint Commission International accreditation which ensures safety standards for complex brain tumor removals.
Patient Consensus: Patients note that public registration involves heavy paperwork but eventually eliminates most medication costs. Many recommend bringing organized pathology records to speed up the required second opinions before surgery.